A potential immunotherapy strategy for early-stage prostate cancer

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

Novel delivery method bypasses blood-brain barrier to treat ALS symptoms

A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic lateral sclerosis (ALS), the neurodegenerative disorder commonly known as Lou ...

If you're struggling to lose weight, could chilling your carbs help?

If you eat a diet high in refined starches, chilling can technically mitigate some of their negative impacts. But Dr. Walter ...

Antibody developed to protect immune system cells in vitro from a dangerous hospital-acquired bacterium

A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of Catalonia (IQAC), part of the Spanish National Research Council (CSIC), ...

First-ever in-utero stem cell therapy for fetal spina bifida repair shows safe results

A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a ...

Immune blueprint maps how the system fights most widespread form of malaria parasite

New research co-led by Burnet Institute and WEHI has uncovered how the human immune system fights Plasmodium vivax, paving the way for the first effective vaccine against the most widespread form of ...

Hypertension treatment linked to lower mortality for patients with metastatic breast cancer

Women with metastatic breast cancer often face multiple chronic conditions, and high blood pressure is among the most common. Nearly half of women in this study population had hypertension at ...

FDA approves Dupixent for allergic fungal rhinosinusitis

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients ...

There is more than one way for triple-negative breast cancer to become resistant to therapy

About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy. When resistance arises, tumors are more likely to come back after the original treatment, significantly ...

Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

What a map of Queensland reveals about health inequality

Researchers have used geospatial data to illustrate significant life expectancy differences across Queensland, including for ...

How to protect your skin from UV damage for as little as $40 a year

Consumers can protect their skin from damaging ultraviolet (UV) light rays for as little as $40 a year—or as much as $1,400 a ...